Indeed, the BM of ALL patients is particularly rich in pro-inflammatory cytokines at diagnosis as demonstrated by the high levels of Interleukin (IL)6, IL1β and Tumor Necrosis Factor (TNFα) that have been detected in the BM of B-ALL patients at diagnosis [53]. The gene discussed is TNF; the disease is precursor B-cell acute lymphoblastic leukemia.